{"protocolSection":{"identificationModule":{"nctId":"NCT00763217","orgStudyIdInfo":{"id":"CP 05/15"},"secondaryIdInfos":[{"id":"PHRC 2004/1901","type":"OTHER","domain":"DHOS"}],"organization":{"fullName":"University Hospital, Lille","class":"OTHER"},"briefTitle":"Clinical Biological and Pharmacological Factors Influencing Stroke Outcome","officialTitle":"Characterization of Clinical, Biological and Pharmacological Markers of Stroke Outcome","acronym":"biostroke"},"statusModule":{"statusVerifiedDate":"2015-05","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2005-06"},"primaryCompletionDateStruct":{"date":"2009-06","type":"ACTUAL"},"completionDateStruct":{"date":"2012-06","type":"ACTUAL"},"studyFirstSubmitDate":"2008-09-26","studyFirstSubmitQcDate":"2008-09-29","studyFirstPostDateStruct":{"date":"2008-09-30","type":"ESTIMATED"},"lastUpdateSubmitDate":"2015-05-12","lastUpdatePostDateStruct":{"date":"2015-05-13","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"University Hospital, Lille","class":"OTHER"},"collaborators":[{"name":"Institut National de la Santé Et de la Recherche Médicale, France","class":"OTHER_GOV"}]},"oversightModule":{"oversightHasDmc":false},"descriptionModule":{"briefSummary":"In a previous suty, we have demonstrated that prior transient ischemic attack, treatment lipid-lowering drug or physical activity are associated to a better outcome of stroke. The aim of the study is to understand the mechanisms of this preventive neuroprotection by establishing link between biomarkers and preventive and neuroprotective measures.To answer to the question, we conduct a cohort study of stroke patients.","detailedDescription":"In the cohort, the severity of stroke (NIHSS) will be correlated with :\n\n* clinical factors,\n* pharmacological factors,\n* biological factors (inflammatory markers, hemostasis...)"},"conditionsModule":{"conditions":["Stroke"],"keywords":["inflammation","coagulation","neuroprotection","drugs","clinical neurology","pharmacology","biological factors"]},"designModule":{"studyType":"OBSERVATIONAL","designInfo":{"observationalModel":"COHORT","timePerspective":"PROSPECTIVE"},"bioSpec":{"retention":"SAMPLES_WITHOUT_DNA","description":"whole blood and serum"},"enrollmentInfo":{"count":550,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"stroke patient cohort","description":"Patients with an hemispheric ischemic or hemorrhage stroke hospitalized during the 48h following the beginning of stroke"}]},"outcomesModule":{"primaryOutcomes":[{"measure":"severity of stroke measured by NIH severity score","timeFrame":"inclusion, day7, month3, year3"}],"secondaryOutcomes":[{"measure":"clinical, pharmacological and biological (metabolic, inflammation, hemostasis...) cognitive status","timeFrame":"inclusion and year3"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* ischemic or hemorrhage stroke\n* hemispheric stroke\n* stroke dating from less 48h\n\nExclusion Criteria:\n\n* non hemispheric stroke\n* malformative intracranial hemorrhage\n* traumatic intracranial hemorrhage\n* subarachnoidal hemorrhage","healthyVolunteers":false,"sex":"ALL","minimumAge":"40 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Cohort of stroke patient","samplingMethod":"PROBABILITY_SAMPLE"},"contactsLocationsModule":{"overallOfficials":[{"name":"regis BORDET, MD,PhD","affiliation":"Lille University Hospital","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Lille University Hospital - Service de Neurologie vasculaire","city":"Lille","country":"France","geoPoint":{"lat":50.63297,"lon":3.05858}}]},"referencesModule":{"references":[{"pmid":"30782684","type":"DERIVED","citation":"Colin O, Labreuche J, Deguil J, Mendyk AM, Deken V, Cordonnier C, Deplanque D, Leys D, Bordet R. Preadmission use of benzodiazepines and stroke outcomes: the Biostroke prospective cohort study. BMJ Open. 2019 Jan 15;9(1):e022720. doi: 10.1136/bmjopen-2018-022720."},{"pmid":"26502812","type":"DERIVED","citation":"Moulin S, Leys D, Schraen-Maschke S, Bombois S, Mendyk AM, Muhr-Tailleux A, Cordonnier C, Buee L, Pasquier F, Bordet R. Abeta1-40 and Abeta1-42 Plasmatic Levels In Stroke: Influence of Pre-Existing Cognitive Status and Stroke Characteristics. Curr Alzheimer Res. 2017;14(6):686-694. doi: 10.2174/1567205012666151027141730."}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M9983","name":"Inflammation","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]}},"hasResults":false}